Strides Pharma Science Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 07, 2025
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science Limited has informed the exchanges that its 34th Annual General Meeting (AGM) will be held on Thursday, August 7, 2025 at 11:30 hrs IST via video conferencing (VC/OAVM). Key items on the agenda include adoption of audited financial statements for FY25, declaration of a final dividend of Rs. 4.00 per equity share (face value Rs. 10), and re-appointment of Mr. Aditya Arun Kumar, Executive Director – Business Development and son of founder/Chairperson Arun Kumar, as a director liable to retire by rotation. Shareholders will also vote on appointing M/s V. Sreedharan & Associates as Secretarial Auditor for a 5-year term from FY26 (proposed fee of Rs. 3 lakh for FY26) and approving remuneration of up to Rs. 4.50 lakh for Cost Auditors M/s. Rao, Murthy & Associates for FY26. The record date for dividend entitlement is Tuesday, July 22, 2025, and the e-voting window runs from August 2 to August 6, 2025. The FY25 Annual Report (including the Business Responsibility and Sustainability Report) is being dispatched electronically to shareholders.
The Rs. 4.00 per share final dividend is a routine capital-return subject to shareholder approval and may be mildly positive for income-focused investors. The agenda is largely procedural — re-appointment of a promoter-family executive, auditor appointments, and routine governance items — with no material strategic change signalled.